Solubility and dissolution rate enhancement of lumefantrine using hot melt extrusion technology with physicochemical characterisation

被引：39

作者：

Fule R. ^{[1
]}

Meer T. ^{[1
]}

Sav A. ^{[1
]}

Amin P. ^{[1
]}

机构：

[1] Department of Pharmaceutical Science and Technology, Institute of Chemical Technology, Mumbai, Maharashtra, Matunga (East)

来源：

Journal of Pharmaceutical Investigation | 2013年 / 43卷 / 4期

关键词：

Dissolution rate; Hot melt extrusion; Lumefantrine; Solid dispersion; Solubility;

D O I：

10.1007/s40005-013-0078-z

中图分类号：

学科分类号：

摘要：

The interest in hot-melt extrusion as a drug delivery technology for the production of solid dispersion is growing rapidly. Lumefantrine (LUMF) is an antimalarial drug that exhibits poor oral bioavailability, in consequence of its poor aqueous solubility. To improve its antimalarial activity, solid dispersion formulation using hot melt extrusion technology was prepared. Appropriate selection of polymers, favoured the production of amorphous LUMF-polymer solid dispersions. The physicochemical properties of solid dispersions were characterized using scanning electron microscope, Infrared spectroscopy, differential scanning calorimetry and X-ray diffraction. LUMF SD showed enhanced dissolution rate attributed to amorphosization of LUMF. The IC50 value of LUMF SD formulations was found to be (0.084-0.213 ng/mL) i.e. 220-101 times lower than the IC50 value of pure LUMF (18.2 ng/mL) and 45-18 times lower than the IC50 value of standard antimalarial drug, chloroquine (3.8 ng/mL). Molecular dynamic simulation approach was used to investigate drug-polymer molecular interaction using computational modelling Schrodinger® software. LUMF SD powder makes the Coartem® therapy more operative with value-added beneficial comeback. © 2013 The Korean Society of Pharmaceutical Sciences and Technology.

引用

页码：305 / 321

页数：16

共 30 条

[1]

Almeida A., Possemiers S., Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion, Eur J Pharm Biopharm, 77, pp. 297-307, (2011)

[2]

Ambike A.A., Mahadik K.R., Paradkar A., Stability study of amorphous valdecoxib, Int J Pharm, 282, pp. 151-162, (2004)

[3]

Andriantsoanirina V., Resistance of Plasmodium falciparum to antimalarial drugs: impact on malaria pre-elimination in Madagascar, Med Trop Mars, 1, pp. 298-304, (2011)

[4]

Bacon D.J., Latour C., Picot S., Comparison of a SYBR green i-based assay with a histidine-rich protein ii enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates, Antimicrob Agents Chemother, 51, pp. 1172-1178, (2007)

[5]

Breitenbach J., Melt extrusion: from process to drug delivery technology, Eur J Pharm Biopharm, 54, pp. 107-117, (2002)

[6]

Chiou W.L., Riegelman S., Pharmaceutical applications of solid dispersion systems, J Pharm Sci, 60, pp. 1281-1302, (1971)

[7]

Chokshi R.J., Zia H., Sandhu H.K., Shah N.H., Malick W.A., Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution, Drug Deliv, 14, 1, pp. 33-45, (2007)

[8]

Crowley M.M., Zhang F., Koleng J.J., McGinity J.W., Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion, Biomaterials, 23, pp. 4241-4248, (2002)

[9]

Doshi D.H., Betageri G.V., Carbamazepine and polyethylene glycol solid dispersion preparation, in vitro dissolution, and characterization, Drug Dev Ind Pharm, 23, pp. 1167-1176, (1997)

[10]

Ford J.L., The current status of solid dispersions, Pharm Acta Helvetica, 61, pp. 69-88, (1986)

← 1 2 3 →